{"DataElement":{"publicId":"8123161","version":"1","preferredName":"World Health Organization Classification Acute Lymphoblastic Leukemia Category World Health Organization","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.A United Nations agency established to coordinate international health activities and to help governments improve health services.","longName":"ALL_WHO_CLASS","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8123155","version":"1","preferredName":"World Health Organization Classification","preferredDefinition":"A United Nations agency established to coordinate international health activities and to help governments improve health services._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"8123153v1.0:2321361v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"8123153","version":"1","preferredName":"World Health Organization","preferredDefinition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","longName":"C75419","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4D0245-20EE-5C4E-E053-4EBD850A260F","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4D0245-20FC-5C4E-E053-4EBD850A260F","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"LEEW","dateModified":"2022-04-07","changeDescription":"APAL2020B","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8123156","version":"1","preferredName":"Acute Lymphoblastic Leukemia Category World Health Organization","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia._A grouping of items based on some commonality or by user defined characteristics._A United Nations agency established to coordinate international health activities and to help governments improve health services.","longName":"8123156v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MPAL, T/myeloid, NOS","valueDescription":"MPAL, T/myeloid, NOS","ValueMeaning":{"publicId":"8123157","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, Rare Types","longName":"8123157v1.00","preferredDefinition":"A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, Rare Types","conceptCode":"C151990","definition":"A very rare mixed phenotype acute leukemia in which the blasts express combinations of B, T, myeloid, and megakaryocytic lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A1F8-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":"2023.9.5 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB4DDA1F-A211-31BE-E053-4EBD850A75A5","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"MPAL, B/myeloid, NOS","valueDescription":"MPAL, B/myeloid, NOS","ValueMeaning":{"publicId":"8123158","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, T/Myeloid","longName":"8123158v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, T/Myeloid","conceptCode":"C82213","definition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A21B-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":"2023.9.5 Alt VM added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB4DDA1F-A234-31BE-E053-4EBD850A75A5","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"MPAL with t(v;11q23.3); KMT2A rearranged","valueDescription":"MPAL with t(v;11q23.3); KMT2A rearranged","ValueMeaning":{"publicId":"8123159","version":"1","preferredName":"B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement","longName":"8123159v1.00","preferredDefinition":"B-acute lymphoblastic leukemia associated with ZNF384 gene rearrangement. The prognosis is variable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia with ZNF384 Rearrangement","conceptCode":"C199234","definition":"B-acute lymphoblastic leukemia associated with ZNF384 gene rearrangement. The prognosis is variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A23E-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB4DDA1F-A257-31BE-E053-4EBD850A75A5","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"Mixed phenotype acute leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1","valueDescription":"Mixed phenotype acute leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1","ValueMeaning":{"publicId":"8123160","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with KMT2A Rearrangement","longName":"8123160v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with KMT2A Rearrangement","conceptCode":"C82203","definition":"A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A261-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB4DDA1F-A27A-31BE-E053-4EBD850A75A5","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"Acute Lymphoblastic Leukemia (B-ALL)","valueDescription":null,"ValueMeaning":{"publicId":"4263974","version":"1","preferredName":"B Acute Lymphoblastic Leukemia","longName":"4263974","preferredDefinition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Acute Lymphoblastic Leukemia","conceptCode":"C8644","definition":"The most frequent type of acute lymphoblastic leukemia.  Approximately 75% of cases occur in children under six years of age.  This is a good prognosis leukemia.  In the pediatric age group the complete remission rate is approximately 95% and the disease free survival rate is 70%.  Approximately 80% of children appear to be cured.  In the adult age group the complete remission rate is 60-85%.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1156-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04A36189-2304-19F3-E063-731AD00A5F62","beginDate":"2023-09-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-05","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","deletedIndicator":"No"},{"value":"Acute Lymphoblastic Leukemia (T-ALL)","valueDescription":null,"ValueMeaning":{"publicId":"4263973","version":"1","preferredName":"T Acute Lymphoblastic Leukemia","longName":"4263973","preferredDefinition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T Acute Lymphoblastic Leukemia","conceptCode":"C3183","definition":"Acute lymphoblastic leukemia of T-cell origin.  It comprises about 15% of childhood cases and 25% of adult cases.  It is more common in males than females.  (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1133-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04A36189-2305-19F3-E063-731AD00A5F62","beginDate":"2023-09-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-05","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","deletedIndicator":"No"},{"value":"Mixed Phenotype Acute Leukemia (MPAL - B/T)","valueDescription":null,"ValueMeaning":{"publicId":"6338189","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified","longName":"6338189","preferredDefinition":"A very rare mixed phenotype acute leukemia, not otherwise specified in which the blasts show clear-cut evidence of both B-cell and T-cell lineage. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/T","conceptCode":"C151992","definition":"A very rare mixed phenotype acute leukemia in which the blasts show clear-cut evidence of both B-cell and T-cell lineage but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2889D3-6AD1-431C-E053-F662850A5844","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04A36189-2306-19F3-E063-731AD00A5F62","beginDate":"2023-09-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-09-05","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8123006","version":"1","preferredName":"Acute Lymphoblastic Leukemia Category World Health Organization","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.:A grouping of items based on some commonality or by user defined characteristics.:A United Nations agency established to coordinate international health activities and to help governments improve health services.","longName":"C3167:C25372:C75419","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4C22CA-D372-4994-E053-4EBD850AAB1B","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A1E3-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":"APAL2020B","administrativeNotes":"2023.9.5 PVs added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"World Health Organization (WH","type":"Preferred Question Text","description":"World Health Organization (WHO) disease classification:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Disease type:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB4DDA1F-A28C-31BE-E053-4EBD850A75A5","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":"APAL2020B","administrativeNotes":"2023.9.5 AQT added per ticket request CADSR0002816. ak","unresolvedIssues":null,"deletedIndicator":"No"}}